We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Microbiological Molecular Assay Analyses Heart Valve Tissue

By LabMedica International staff writers
Posted on 05 Feb 2013
Positive heart valve (HV) culture is a major criterion for the diagnosis of infective endocarditis, but is poorly sensitive compared with molecular assays. More...


Molecular methods applied directly to HV tissue have shown promise in negative-culture infective endocarditis and sequencing of the gene encoding 16S ribosomal ribonucleic acid (rRNA) is an accurate means of identifying microorganisms and, offers sensitive and rapid diagnosis.

Scientists at the Central University Hospital at Limoges (CHU; France) applied a two-step broad-range polymerase chain reaction (PCR) and a specific real-time PCR to HV samples and compared the results with those of serologic tests and conventional microbiological methods. This study examined HV samples excised from 31 patients with definite endocarditis based on Duke's modified criteria, between January 1, 2002, and December 31, 2007. The aortic valve was affected in 15 cases and the mitral valve in 16 cases.

Two broad-range PCR methods were applied to the 31 HV samples. The first was a real-time (RT-PCR) method, followed by a conventional end-point PCR that was applied to HV samples on which the first PCR was negative. Five specific RT-PCR procedures were also used in order to identify Bartonella spp., Tropheryma whipplei, Chlamydophila pneumoniae, Mycoplasma pneumonia, and Coxiella burnetii. Blood cultures were positive in 23 cases.

The RT-PCR was positive in 11 of the 23 patients with blood culture-positive endocarditis. All the sequencing results matched the blood culture results to the genus level at least. Seven culture-negative HV specimens gave an amplification product, sequencing of which identified Streptococcus mutans in one patient and Streptococcus anginosus in another patient. Streptococcus gallolyticus was found three patients and Staphylococcus epidermidis in two patients. Specific PCR identified one T. whipplei, which was also identified by conventional end-point PCR.

The authors concluded that the strategy of combining the two-step broad-range PCR methods improved the sensitivity of the molecular method from 38.7% to 58%. Their results confirm that blood culture is still the gold standard for the diagnosis of infective endocarditis, but does show that molecular methods applied to HV can be useful when blood culture is negative. The study was published January 12, 2013, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Central University Hospital at Limoges



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.